Clinical trials
Acquired Immunodeficiency Syndrome trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kirby Institute | 2 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| Albert Einstein College of Medicine | 1 |
| All India Institute of Medical Sciences | 1 |
| Becton, Dickinson and Company | 1 |
| Brigham and Women's Hospital | 1 |
| GlaxoSmithKline | 1 |
| Institute of Health Management, Pachod, India | 1 |
| International Atomic Energy Agency | 1 |
| Janssen Sciences Ireland UC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 23 |
| HIV Infections | 10 |
| Tuberculosis | 3 |
| Uterine Cervical Neoplasms | 3 |
| COVID-19 | 1 |
| Coinfection | 1 |
| Coronavirus Infections | 1 |
| Elephantiasis, Filarial | 1 |
| Hepatitis B | 1 |
| Hepatitis C | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.